DaVita Inc
F:TRL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DaVita Inc
F:TRL
|
US |
|
Polygiene Group AB
F:44P
|
SE |
|
A
|
Assicurazioni Generali SpA
XMUN:ASG
|
IT |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
T
|
Thales SA
DUS:CSF
|
FR |
Wall St Price Targets
TRL Price Targets Summary
DaVita Inc
According to Wall Street analysts, the average 1-year price target for TRL is 97.57 EUR with a low forecast of 67.16 EUR and a high forecast of 130.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TRL's stock price target?
Price Target
97.57
EUR
According to Wall Street analysts, the average 1-year price target for TRL is 97.57 EUR with a low forecast of 67.16 EUR and a high forecast of 130.01 EUR.
What is the Revenue forecast for DaVita Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for DaVita Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for DaVita Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for DaVita Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 2%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for DaVita Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
